STERIS’ (TSE:STE – Free Report) – Equities research analysts at Atb Cap Markets dropped their Q3 2024 earnings per share (EPS) estimates for STERIS’ in a research note issued on Tuesday, October 1st. Atb Cap Markets analyst W. Syed now anticipates that the company will post earnings of $0.19 per share for the quarter, down from their prior estimate of $0.29. Atb Cap Markets also issued estimates for STERIS’’s FY2024 earnings at $0.77 EPS, Q1 2025 earnings at $0.45 EPS, Q3 2025 earnings at $0.31 EPS and Q1 2026 earnings at $0.40 EPS.
STERIS’ (TSE:STE – Get Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported C$0.14 EPS for the quarter, topping the consensus estimate of C$0.12 by C$0.02. The firm had revenue of C$231.38 million for the quarter, compared to analyst estimates of C$226.20 million.
STERIS’ Stock Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Read More
- Five stocks we like better than STERIS’
- Investing in Travel Stocks Benefits
- S&P 500 Hitting Resistance: These 3 Stocks Offer the Best Upside
- 5 discounted opportunities for dividend growth investors
- Nike’s Post-Earnings Drop Presents a Buying Opportunity
- How is Compound Interest Calculated?
- Microsoft’s Targeted Upside Might Be Too Good to Ignore
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
